DFCM
NKTR icon

Dark Forest Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Dark Forest Capital Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-42,277
Closed -$1.79M – 1025
2025
Q4 		$1.79M Buy
42,277
+33,092
+360% +$1.85M 0.08% 436
2025
Q3 		$523K Buy
+9,185
New +$304K 0.02% 915
2023
Q2 		– Sell
-29
Closed -$302 – 1273
2023
Q1 		$302 Buy
+29
New +$877 ﹤0.01% 1114
2022
Q4 		– Sell
-188
Closed -$9K – 1380
2022
Q3 		$9K Buy
188
+179
+1,989% +$10.6K ﹤0.01% 768
2022
Q2 		$0 Buy
+9
New +$568 ﹤0.01% 1211
2022
Q1 		– Sell
-1
Closed – – 1599
2021
Q4 		$0 Sell
1
-3
-75% -$651 ﹤0.01% 1672
2021
Q3 		$1K Buy
+4
New +$962 ﹤0.01% 1204

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dark Forest Capital Management's NKTR Position: Q1 2026 in Review

Dark Forest Capital Management sold out of Nektar Therapeutics (NKTR) in Q1 2026, closing a stake of 42,277 shares — an estimated $1.79M sold.

Dark Forest Capital Management first reported a position in NKTR in Q3 2021 and held it in 7 quarters. The position peaked at $1.79M in Q4 2025. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Dark Forest Capital Management reported no remaining Nektar Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 42,277 Nektar Therapeutics shares in Q1 2026, an estimated $1.79M.
  • Dark Forest Capital Management first reported a position in Nektar Therapeutics in Q3 2021 and held it in 7 quarters.
  • Dark Forest Capital Management's Nektar Therapeutics position peaked at $1.79M in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.